ACTON, Mass. (AP) — ACTON, Mass. (AP) — Insulet Corp. (PODD) on Thursday reported fourth-quarter profit of $100.7 million.
On a per-share basis, the Acton, Massachusetts-based company said it had profit of $1.39. Earnings, adjusted for non-recurring gains, were $1.15 per share.
The results beat Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $1.05 per share.
The maker of insulin infusion systems posted revenue of $597.5 million in the period, also surpassing Street forecasts. Nine analysts surveyed by Zacks expected $581.7 million.
For the year, the company reported profit of $418.3 million, or $5.78 per share. Revenue was reported as $2.07 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PODD at https://www.zacks.com/ap/PODD
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
